26 related articles for article (PubMed ID: 22871127)
1. Targeting Breast Cancer Using 177 Lu-Labeled Trastuzumab and Trastuzumab Fragment : First-in-Human Clinical Experience.
Rathore Y; Lakhanpal T; Chakraborty S; Chakravarty R; Mittal BR; Irrinki RNS; Laroiya I; Kaur K; Shukla J
Clin Nucl Med; 2024 Jun; 49(6):e258-e265. PubMed ID: 38579266
[TBL] [Abstract][Full Text] [Related]
2. Development of Novel Trifunctional Chelating Agents That Enhance Tumor Retention of Radioimmunoconjugates.
Nakashima K; Watanabe H; Ono M
J Med Chem; 2023 Sep; 66(18):12812-12827. PubMed ID: 37721492
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties.
Miranda ACC; Dos Santos SN; Fuscaldi LL; Balieiro LM; Bellini MH; Guimarães MICC; de Araújo EB
Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34198999
[TBL] [Abstract][Full Text] [Related]
4. MIB Guides: Measuring the Immunoreactivity of Radioimmunoconjugates.
Delaney S; Grimaldi C; Houghton JL; Zeglis BM
Mol Imaging Biol; 2024 Apr; 26(2):213-221. PubMed ID: 38446323
[TBL] [Abstract][Full Text] [Related]
5. Backbone and methyl side-chain resonance assignments of the single chain Fab fragment of trastuzumab.
Gagné D; Aramini JM; Aubin Y
Biomol NMR Assign; 2024 May; ():. PubMed ID: 38717571
[TBL] [Abstract][Full Text] [Related]
6. Nanostructures as Radionuclide Carriers in Auger Electron Therapy.
Gharibkandi NA; Gierałtowska J; Wawrowicz K; Bilewicz A
Materials (Basel); 2022 Feb; 15(3):. PubMed ID: 35161087
[TBL] [Abstract][Full Text] [Related]
7. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).
Sliwkowski MX; Lofgren JA; Lewis GD; Hotaling TE; Fendly BM; Fox JA
Semin Oncol; 1999 Aug; 26(4 Suppl 12):60-70. PubMed ID: 10482195
[TBL] [Abstract][Full Text] [Related]
8. Cupid and Psyche system for the diagnosis and treatment of advanced cancer.
Sugiyama A; Kawamura T; Tanaka T; Doi H; Yamashita T; Shinoda K; Fujitani H; Yamatsugu K; Shimizu Y; Tatsumi T; Takahashi K; Kanai M; Mizohata E; Kawato T; Doi T; Inoue T; Kodama T
Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(10):602-611. PubMed ID: 31827018
[TBL] [Abstract][Full Text] [Related]
9. Biotinylated polyacrylamide-based metal-chelating polymers and their influence on antigen recognition following conjugation to a trastuzumab Fab fragment.
Liu P; Boyle AJ; Lu Y; Reilly RM; Winnik MA
Biomacromolecules; 2012 Sep; 13(9):2831-42. PubMed ID: 22871127
[TBL] [Abstract][Full Text] [Related]
10. Metal-Chelating Polymers (MCPs) with Zwitterionic Pendant Groups Complexed to Trastuzumab Exhibit Decreased Liver Accumulation Compared to Polyanionic MCP Immunoconjugates.
Liu P; Boyle AJ; Lu Y; Adams J; Chi Y; Reilly RM; Winnik MA
Biomacromolecules; 2015 Nov; 16(11):3613-23. PubMed ID: 26469142
[TBL] [Abstract][Full Text] [Related]
11. Intracellular routing in breast cancer cells of streptavidin-conjugated trastuzumab Fab fragments linked to biotinylated doxorubicin-functionalized metal chelating polymers.
Liu P; Cai Z; Kang JW; Boyle AJ; Adams J; Lu Y; Ngo Ndjock Mbong G; Sidhu S; Reilly RM; Winnik MA
Biomacromolecules; 2014 Mar; 15(3):715-25. PubMed ID: 24506198
[TBL] [Abstract][Full Text] [Related]
12. The effect of metal-chelating polymers (MCPs) for 111In complexed via the streptavidin-biotin system to trastuzumab Fab fragments on tumor and normal tissue distribution in mice.
Boyle AJ; Liu P; Lu Y; Weinrich D; Scollard DA; Ngo Njock Mbong G; Winnik MA; Reilly RM
Pharm Res; 2013 Jan; 30(1):104-16. PubMed ID: 22907419
[TBL] [Abstract][Full Text] [Related]
13. Small-animal SPECT/CT of HER2 and HER3 expression in tumor xenografts in athymic mice using trastuzumab Fab-heregulin bispecific radioimmunoconjugates.
Razumienko EJ; Scollard DA; Reilly RM
J Nucl Med; 2012 Dec; 53(12):1943-50. PubMed ID: 23096164
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
